Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1971.59% is 83% above its 5-year average of -11681.26%, near the low end of its 5-year range (-89117.65%–9219600.00%).
75.83% above its 12-month average of -8157.33%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -25949.71%.
OPERATING MARGIN
-1971.59%
OPERATING MARGIN AVG TTM
-8157.33%
OPERATING MARGIN AVG 3Y
-642.89%
OPERATING MARGIN AVG 5Y
-11681.26%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+75.83%
CURRENT VS 3Y AVG
-206.68%
CURRENT VS 5Y AVG
+83.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Relay Therapeutics, Inc.
Market Cap
$4.11B
Operating Margin
-1971.59%
TTM Avg
-8157.33%
3Y Avg
-642.89%
5Y Avg
-11681.26%
Market Cap
$4.02B
Operating Margin
-288.98%
TTM Avg
-690.34%
3Y Avg
-489.97%
5Y Avg
-306.42%
Market Cap
$4.31B
Operating Margin
-20.62%
TTM Avg
-55.73%
3Y Avg
-88.20%
5Y Avg
-107.26%
Market Cap
$4.31B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.37B
Operating Margin
-34.31%
TTM Avg
-42.52%
3Y Avg
-56.23%
5Y Avg
-56.23%
Market Cap
$4.48B
Operating Margin
21.39%
TTM Avg
12.04%
3Y Avg
0.21%
5Y Avg
0.61%
Market Cap
$3.64B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | $4.11B | -1971.59% | -8157.33% | -642.89% | -11681.26% |
| LivaNova PLC (LIVN)vs › | $4.12B | 13.48% | 12.33% | 2.80% | -3.03% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | -288.98% | -690.34% | -489.97% | -306.42% |
| ICU Medical, Inc. (ICUI)vs › | $3.99B | 5.04% | 3.30% | 1.43% | 3.80% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.31B | -20.62% | -55.73% | -88.20% | -107.26% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.31B | 0.00% | 0.00% | 0.00% | 0.00% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.37B | -34.31% | -42.52% | -56.23% | -56.23% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | 21.39% | 12.04% | 0.21% | 0.61% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | 0.00% | 0.00% | 0.00% | 0.00% |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 10.90% | -12.82% | -40.85% | -40.85% |
Gross Margin
76.8%
Operating Margin
-1971.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -25949.71% |
| 2026-03-31 | -2619.67% |
| 2025-12-31 | -866.16% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | -11351.11% |
| 2025-03-31 | -1105.21% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | -903.00% |
| 2023-12-31 | 9219600.00% |
| 2023-09-30 | -291.95% |
| 2023-06-30 | -89117.65% |
| 2023-03-31 | -44768.58% |
| 2022-12-31 | -28794.86% |
| 2022-09-30 | -24968.60% |
| 2022-06-30 | -21318.08% |
| 2022-03-31 | -14969.21% |
| 2021-12-31 | -11944.09% |
| 2021-09-30 | -9157.66% |
| 2021-06-30 | -22936.02% |
| 2021-03-31 | -4454.31% |
| 2020-12-31 | 42.33% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
